The Ledger

Every statement that passed quotation and attribution checks. Mix any filter with any other: certainty 1/5, debate potential 5/5, or both at once.

clear all ✕

why aren't all 8 resolved? a statement only gets an assessment when the public record can support or contradict it. opinions and what-ifs never can, and 0 checkable ones are still open, waiting for their date. predictions held up or didn't; assertions are supported or contradicted. on every card: ▮▮▮▮▮ certainty · ▮▮▮▮▮ debate potential. speakers are clickable

Prediction Held up
No New Major Pharma Companies Will Be Built From Biotech VC
“There are very few, there won't be any new major pharmaceutical companies created out of biotech VC money anymore. Really all about creating companies that can exit to these people.”
Peter Parker Jun 11, 2018 ▶ 22:46 20VC: Why Process is Everything In Good Venture Firms, Why GPs Should Have More Empathy For LPs and Lessons from 32 Years In VC, Chairing Over 25 Boards with Peter Parker, Managing Partner @ Bioinnovation Capital
Prediction Not checkable as stated
BioInnovation Capital Targets Gains on Two-Thirds of Portfolio Companies
“I'd like to see a portfolio with two thirds of my companies being gains for us. And so not relying on the 50 to one winner to Drive the whole portfolio. I think that's just too hard to do.”
Peter Parker Jun 11, 2018 ▶ 27:23 20VC: Why Process is Everything In Good Venture Firms, Why GPs Should Have More Empathy For LPs and Lessons from 32 Years In VC, Chairing Over 25 Boards with Peter Parker, Managing Partner @ Bioinnovation Capital
Assertion Not checkable as stated
BioInnovation Capital Converts 100% of LPs Who Visit Their Lab Space
“When we can get an LP there, meaning this may say the second meeting is at our shop, I think we've gotten a hundred percent of those people to invest in the funds.”
Peter Parker Jun 11, 2018 ▶ 16:30 20VC: Why Process is Everything In Good Venture Firms, Why GPs Should Have More Empathy For LPs and Lessons from 32 Years In VC, Chairing Over 25 Boards with Peter Parker, Managing Partner @ Bioinnovation Capital
Prediction Not checkable as stated
BioInnovation Capital Targets Portfolio Exits Under $50M Total Funding
“So we like to say the companies have to be able to exit by the time fifty million dollars of venture money has gone in.”
Peter Parker Jun 11, 2018 ▶ 26:36 20VC: Why Process is Everything In Good Venture Firms, Why GPs Should Have More Empathy For LPs and Lessons from 32 Years In VC, Chairing Over 25 Boards with Peter Parker, Managing Partner @ Bioinnovation Capital
Assertion Not checkable as stated
No VC Firms Called Themselves Life Sciences Funds in the Late 1980s
“So back in the late eighties, there were very few specialized firms at all. None that I knew of that would call themselves, for instance, life sciences firms.”
Peter Parker Jun 11, 2018 ▶ 5:35 20VC: Why Process is Everything In Good Venture Firms, Why GPs Should Have More Empathy For LPs and Lessons from 32 Years In VC, Chairing Over 25 Boards with Peter Parker, Managing Partner @ Bioinnovation Capital
Assertion Contradicted
Pharma Internal Research Headcount Dropped 5-6% Annually Over the Past Decade
“If you look at the last 10 years, the research headcount in pharma has gone down by five or six percentage points per annum, so they're half as big internal research, but now what they've done is created external R&D groups, so they're out shopping, and we hav…”
Peter Parker Jun 11, 2018 ▶ 24:49 20VC: Why Process is Everything In Good Venture Firms, Why GPs Should Have More Empathy For LPs and Lessons from 32 Years In VC, Chairing Over 25 Boards with Peter Parker, Managing Partner @ Bioinnovation Capital
Assertion Contradicted
3M Post-It Note Was Invented to Communicate With CEO
“Three M is a great example of this, where the post-it note was famously invented by someone who just needed a way to communicate with the CEO on a piece of sticky paper.”
Peter Parker Jun 11, 2018 ▶ 3:47 20VC: Why Process is Everything In Good Venture Firms, Why GPs Should Have More Empathy For LPs and Lessons from 32 Years In VC, Chairing Over 25 Boards with Peter Parker, Managing Partner @ Bioinnovation Capital
Assertion Not checkable as stated
The VC Industry Had Only 200 Firms Worldwide in the Late 1980s
“There were probably, we thought, maybe 200 venture firms in the world, and in those days, the U.S. Was the predominant player in venture capital. Now, this is early stage venture capital. A lot of these were efforts that spun out of investment banks or other e…”
Peter Parker Jun 11, 2018 ▶ 5:00 20VC: Why Process is Everything In Good Venture Firms, Why GPs Should Have More Empathy For LPs and Lessons from 32 Years In VC, Chairing Over 25 Boards with Peter Parker, Managing Partner @ Bioinnovation Capital
Made with StarZero

Turn any episode into a week of clips.

This entire site, over 1,200 episodes transcribed, diarized, checked and made playable, runs on the StarZero media pipeline. Drop in your own episode and the podcast clipper finds the moments worth sharing, cuts them, captions them, and reframes them for every feed.